Inspire Investing’s Kura Oncology KURA Stock Holding History

Inspire Investing’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,905	Closed	-$274K	–	850
2023 Q2	$274K	Buy	25,905 +1,229	+5%	+$14.5K	0.03%	779
2023 Q1	$302K	Buy	+24,676	New	+$308K	0.04%	399

Other funds holding KURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Inspire Investing's KURA Position: Q3 2023 in Review

Inspire Investing sold out of Kura Oncology (KURA) in Q3 2023, closing a stake of 25,905 shares — an estimated $274K sold.

Inspire Investing first reported a position in KURA in Q1 2023 and held it in 2 quarters. The position peaked at $302K in Q1 2023. 133 funds tracked by Wall St. Rank hold KURA as of Q3 2023.

Inspire Investing reported no remaining Kura Oncology position as of Q3 2023 after selling out during the quarter.
Inspire Investing sold 25,905 Kura Oncology shares in Q3 2023, an estimated $274K.
Inspire Investing first reported a position in Kura Oncology in Q1 2023 and held it in 2 quarters.
Inspire Investing's Kura Oncology position peaked at $302K in Q1 2023.
133 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2023.

Based on Inspire Investing's 13F filing for Q3 2023, filed 26 Oct 2023.